191 related articles for article (PubMed ID: 12910516)
1. The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Kawauchi A; Nakao M; Miki T
Cancer; 2003 Aug; 98(4):730-6. PubMed ID: 12910516
[TBL] [Abstract][Full Text] [Related]
2. High levels of thymidine phosphorylase as an independent prognostic factor in renal cell carcinoma.
Takayama T; Mugiya S; Sugiyama T; Aoki T; Furuse H; Liu H; Hirano Y; Kai F; Ushiyama T; Ozono S
Jpn J Clin Oncol; 2006 Sep; 36(9):564-9. PubMed ID: 16861722
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T
Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
5. Significance of thymidine kinase activity in renal cell carcinoma.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Nakao M; Miki T
J Urol; 2003 Feb; 169(2):706-9. PubMed ID: 12544347
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma.
Mizutani Y; Wada H; Fukushima M; Yoshida O; Nakanishi H; Li YN; Miki T
Cancer; 2004 Feb; 100(4):723-31. PubMed ID: 14770427
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
van Triest B; Pinedo HM; Blaauwgeers JL; van Diest PJ; Schoenmakers PS; Voorn DA; Smid K; Hoekman K; Hoitsma HF; Peters GJ
Clin Cancer Res; 2000 Mar; 6(3):1063-72. PubMed ID: 10741735
[TBL] [Abstract][Full Text] [Related]
8. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma.
Imazano Y; Takebayashi Y; Nishiyama K; Akiba S; Miyadera K; Yamada Y; Akiyama S; Ohi Y
J Clin Oncol; 1997 Jul; 15(7):2570-8. PubMed ID: 9215827
[TBL] [Abstract][Full Text] [Related]
9. Expression of platelet-derived endothelial cell growth factor in bladder carcinoma.
Mizutani Y; Okada Y; Yoshida O
Cancer; 1997 Mar; 79(6):1190-4. PubMed ID: 9070497
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
11. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
[TBL] [Abstract][Full Text] [Related]
12. Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder.
Arima J; Imazono Y; Takebayashi Y; Nishiyama K; Shirahama T; Akiba S; Furukawa T; Akiyama S; Ohi Y
Cancer; 2000 Mar; 88(5):1131-8. PubMed ID: 10699904
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of thymidine kinase activity in bladder carcinoma.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Kamoi K; Miki T
Cancer; 2002 Nov; 95(10):2120-5. PubMed ID: 12412165
[TBL] [Abstract][Full Text] [Related]
14. Significance of thymidine phosphorylase in HCC with chronic liver disease for long-term postoperative recurrence.
Ezaki T; Ikegami T; Ishida T; Aimitsu S; Mori M; Fujihara M
J Surg Oncol; 2003 Jul; 83(3):173-9; discussion 179. PubMed ID: 12827687
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis.
Creamer D; Jaggar R; Allen M; Bicknell R; Barker J
Br J Dermatol; 1997 Dec; 137(6):851-5. PubMed ID: 9470899
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages.
Toge H; Inagaki T; Kojimoto Y; Shinka T; Hara I
Int J Urol; 2009 Oct; 16(10):801-7. PubMed ID: 19811548
[TBL] [Abstract][Full Text] [Related]
18. Impact of thymidine phosphorylase-expressing macrophages for surgical margin in partial nephrectomy.
Liu H; Takayama T; Ogawa H; Kai F; Sugiyama T; Aoki T; Harada M; Otsuka A; Furuse H; Kurita Y; Mugiya S; Ushiyama T; Ozono S
Urol Int; 2009; 82(4):388-93. PubMed ID: 19506403
[TBL] [Abstract][Full Text] [Related]
19. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers.
O'Brien TS; Fox SB; Dickinson AJ; Turley H; Westwood M; Moghaddam A; Gatter KC; Bicknell R; Harris AL
Cancer Res; 1996 Oct; 56(20):4799-804. PubMed ID: 8841001
[TBL] [Abstract][Full Text] [Related]
20. Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker.
Luo P; He E; Eriksson S; Zhou J; Hu G; Zhang J; Skog S
Eur J Cancer Prev; 2009 Jun; 18(3):220-4. PubMed ID: 19282758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
